Preterm birth accounts for the majority of neonatal morbidity and mortality in the developed world. A significant proportion of cases of spontaneous preterm labor are attributable to infections within gestational tissues. Surfactant protein A (SP-A), a collectin produced in the fetal lung and other tissues, has been shown previously in mice to suppress preterm delivery due to intrauterine (IU) instillation of sterile proinflammatory substances. Here we report a powerful antilabor effect for SP-A after IU infection with live Escherichia coli. SP-A abolished preterm birth (rate reduced from 100% to 0%) when it was administered into the uterus simultaneously with bacterial infection, reducing it by 75% when administered intravenously at the same time as IU bacterial inoculation, and by 48% when administered intravenously 4 h after IU bacterial infection. This effect on preterm delivery was accompanied by a parallel benefit on fetal survival in utero. SP-A had no effect on bacterial growth but reversed several major consequences of infection, including increased production of inflammatory mediators and a shift in macrophage polarization to the M1 phenotype. These findings suggest that exogenous SP-A has potential use to counteract infection-induced labor by reversing its proinflammatory consequences.
Introduction
Preterm birth is the most important cause of neonatal morbidity and mortality not due to congenital anomalies in the developed world [1] . Up to 40% of cases of preterm labor are associated with infection in the gestational compartment [2] . Although in individual cases it may be difficult to determine whether infection is a cause or a
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For permissions, please e-mail: journals.permissions@oup.com consequence of labor, it has become clear that infection and inflammation represent important and frequent underlying causes of the preterm labor syndrome. The most commonly hypothesized mechanism underlying infection-induced labor is ascending colonization of the gestational cavity by vaginal pathogens, with other cases attributed to transplacental hematogenous transmission [1] . Toll-like receptors (TLRs) are a family of membrane-bound proteins that recognize pathogen-associated molecular patterns and mediate innate immune responses [3] [4] [5] . Binding of TLRs is the initial event in activation of the innate immune system, which leads to nuclear translocation of the transcription factor NF-κB and the elaboration of a network of inflammatory mediators.
Surfactant protein (SP)-A, an endogenous ligand for TLR2 [6] [7] [8] and TLR4 [9] , is of particular relevance to human gestation. SP-A is synthesized by the fetal lung starting in the 28th week of human pregnancy, reaching fully functional levels at about the 34th week [10, 11] . In addition to the lung, SP-A is produced in other cells and tissues, including those of the female reproductive tract [12] [13] [14] [15] . SP-A is a member of the collectin family of proteins. Collectins have a Cterminal globular region with a carbohydrate recognition domain (or lectin domain), a hydrophobic alpha-helical neck region, a collagenlike region with Gly-X-Y repeats, and an N-terminal disulfide bondforming region [16] .
Using mouse models, we demonstrated previously that exogenous SP-A suppresses TLR ligand-induced preterm delivery and inflammation [17] . Those experiments, like most animal models of infectioninduced preterm delivery, used bacterial extracts and analogs that activate TLRs [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . These models, while convenient and reproducible, have limited fidelity to potentially important elements of spontaneous intrauterine (IU) infection. For example, spontaneous infection evolves from seeding by a small number of organisms, while most extant animal models of preterm labor involve abrupt exposure to large quantities of an exogenous stimulus. Also, co-factors that modulate microbial virulence may be eliminated during processing of inflammatory extracts. Furthermore, the interplay of innate and acquired immune pathways that occurs during live infections may be circumvented by administration of nonliving inflammatory stimuli. Additional disadvantages of alternative models include their focus on inflammation's deleterious outcomes (e.g. tissue damage, shock, organ failure, and uterine contractions) at the cost of ignoring its beneficial role in clearing infection. The distinction between these two complementary aspects of inflammation for the genesis of labor is important, and understanding them requires studying live infection, which has been conducted only sparingly in mice [22, [27] [28] [29] [30] [31] and in nonhuman primates [32] [33] [34] .
Here, we test the effects of SP-A on the labor-and inflammationinducing actions of live bacteria. We find that SP-A produces a marked suppression of preterm labor induced by live Escherichia coli. This suppressive effect occurs whether the SP-A is administered in the same compartment as the bacterial exposure (i.e. the uterine cavity) or systemically (intravenously), and whether treatment occurs simultaneously or in delayed fashion (i.e. 4 h after bacteria). These effects of SP-A are not mediated through suppression of bacterial growth, but instead are accompanied by diminished inflammation and by diversion of macrophage phenotype away from bacterially induced M1 polarization toward a baseline state.
Materials and methods

Mice
All procedures involving animals were approved by the NorthShore University HealthSystem Animal Care and Use Committee and conform to the Guide for Care and Use of Laboratory Animals (1996, National Academy of Sciences).
Surfactant protein A purification
SP-A was purified from bronchial lavage fluid collected from patients with alveolar proteinosis. The lavage fluid was donated by and was processed according to method reported by Condon et al. [35] with slight modifications [17] . Briefly, lavage fluid was delipidated by centrifugation at 10,000 rpm for 10 min at 4
• C. The supernatant was discarded and a mix of isopropyl ether/1-butanol/RNAse-free water was added. The solution was vortexed vigorously every 5 min for 30 min and frozen overnight at −80 • C, then centrifuged at 2500 rpm for 10 min. The upper organic layer was discarded. The protein was ethanol-precipitated from the aqueous layer and suspended in cold RNAse-free water. Serum albumin was removed by extraction on a DEAE-Affigel blue column (Bio-Rad). Endotoxin decontamination was done using polymyxin B agarose (Sigma) at 37
• C for 30 min.
The endotoxin content in SP-A was ∼0.3 pg/μg of protein as determined by the LAL chromogenic kit (Pierce). Purity of the delipidated, DEAE-Affigel blue-and polymyxin B-treated SP-A preparation was assessed by Coomassie blue staining and western blot analysis using an SP-A-specific antibody (Supplementary Figure S1 ). Protein concentration was checked by BCA protein assay (Thermo Fisher Scientific, Waltham, MA).
Depleted surfactant protein A preparation
A control solution largely depleted of SP-A was prepared by passing the SP-A-enriched preparation over a D-Mannose-Agarose column (Sigma) [35] . The SP-A-depleted preparation was examined for remaining SP-A content by western blot analysis (Supplementary Figure S1 ).
Bacterial preparation
Escherichia coli bacteria (ATCC No. 12014, isolated from a patient with urosepsis) were cultured to log-phase growth according to the method described previously with slight modifications [22] . The day before each experiment, an aliquot of bacteria (from a previously frozen stock) was grown in Luria-Bertani (LB) medium for 16 h in stationary culture at 37
• C. This overnight culture was then diluted and brought to log-phase growth by placing 100 μl in 5 ml of fresh medium for 4 h at 37
• C. This suspension was then diluted by a factor of 10 8 immediately prior to the experiment, and 20 μl of this dilution or of sterile LB medium (a control) was used for IU inoculations (brought to a volume of 100 μl with room-temperature SP-A extract and/or saline). This protocol reliably results in an inoculum of 1-3 × 10 3 E. coli organisms per mouse. The actual inoculum was determined post hoc by serial dilution and plating (done before injecting the first animal in each session and after the last to account for possible continued bacterial growth at room temperature while surgeries were being performed).
Surgical procedures
For pregnancy outcome experiments, CD-1 female mice in estrus were selected by the gross appearance of the vaginal epithelium and were impregnated naturally [36] . Mating was confirmed by the presence of a vaginal plug. Intrauterine injections were performed on day 14.5 of a 19-20 day gestation, as described previously [17] . Briefly, animals were anesthetized with 0.015 ml/g body weight of Avertin (2.5% tribromoethyl alcohol and 2.5% tert-amyl alcohol in PBS). A 1.5-cm midline incision was made in the lower abdomen. In the mouse, the uterus is a bicornuate structure in which the fetuses are arranged in a "beads-on-a-string" pattern. Mice underwent injection of live E. coli or sterile control solution in the midsection of the right uterine horn at a site between two adjacent fetuses, taking care not to inject individual fetal sacs. SP-A (100 or 200 μg, dosing based upon preliminary dose-response experiments) or medium was administered by one of two routes and in one of two schedules: (1) IU simultaneously with bacterial injection; (2) intravenous (IV) simultaneously with bacterial injection; (3) IV 4 h after bacterial injection. Surgical procedures lasted approximately 10 min. The abdomen was closed in two layers, with 4-0 polyglactin sutures at the peritoneum and wound clips at the skin. Intravenous injections were performed via tail vein after closure of the abdomen, either while the animal was still anesthetized (for simultaneous injections) or using a restrainer tube (for 4-h delayed injections). A separate group of animals was studied using the depleted SP-A preparation given IU simultaneously after live E. coli IU injection.
Animals recovered in individual, clean cages in the animal facility. Observations were made twice daily for both preterm delivery and maternal health status. Preterm delivery was defined as the finding of at least one fetus in the cage or in the lower vagina within 48 h of surgery. Necropsies were performed either after delivery or at the latest by 48 h after surgery. The number of fetuses delivered or remaining in utero and the survival status of these retained fetuses (as determined by cardiac or vascular pulsations in the fetal bodies or membranes) were recorded.
Tissue harvest for molecular and flow cytometry assays
A separate group of pregnant mice was used for tissue harvests. These animals received one of four treatments: (1) sterile injection IU with simultaneous diluent IV; (2) live E. coli IU with simultaneous diluent IV; (3) sterile injection IU with simultaneous SP-A IV (200 μg by tail vein); (4) live E. coli IU with simultaneous SP-A IV. Eight hours after surgery mice were euthanized, and the inoculated horn was incised longitudinally along the anti-mesenteric border. Tissues (uterus, decidualized caps of the endometrium, nondecidualized uterus, and placentas), were harvested from the injected uterine horn, washed in ice-cold PBS, flash-frozen in liquid nitrogen, and stored at −80
• C for later mRNA and protein extraction. Separate decidual caps and lumbar lymph nodes (two per animal) were excised and minced in DMEM to produce single-cell suspensions for flow cytometry.
Quantitation of bacterial colony counts in tissues and amniotic fluid
At the time of tissue harvest, uterine wall (∼0.02 mg) and amniotic fluid (50 μl) were collected from sites adjacent to the point of IU injection. Uterine wall was homogenized in LB medium. Homogenate and amniotic fluid were serially diluted and plated on agar plates and incubated for 12 h. Bacterial loads in the uterus and amniotic fluid were calculated and are presented as CFU/g and CFU/μl, respectively.
Real-time PCR
Total RNA from gestational tissues was extracted after homogenization in Trizol reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. Complementary DNA was prepared using qScript cDNA super mix (Quanta Biosciences, Beverly, MA). Duplex RT-PCR was performed with one primer pair amplifying the gene of interest and the other an internal reference (GAPDH) in the same tube using the universal PCR master mix reagent in the Applied Biosystems
Step One Real-time PCR system (Thermo Fisher Scientific). Semiquantitative analysis of gene expression was done using the comparative CT ( CT) method, normalizing the gene of interest to GAPDH. Prevalidated TaqMan gene expression assays were used for IL-1β (Mm00434228), TNFα (Mm00443258), IL-6 (Mm00446190 m1), iNOS (Mm00440502 m1), Nlrp3 (Mm00840904 m1), CCL5 (Mm01302428), CCL2/MCP-1 (Mm00441242 m1), IL-22 (Mm01226722), IL-22 receptor (Mm01192943), IL-10 (Mm00439614), LC3B (Map1lc3B, Mm00782868 sH), and Gapdh (4352339E).
Protein extraction
Decidual tissue was homogenized in ice-cold 1X RIPA buffer (Santa Cruz Biotechnology, Dallas, TX) containing protease and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN). Lysates were incubated on ice for 30 min and centrifuged at 10,000 g for 10 min at 4
• C. Supernatant fluid was collected and used as a total cell lysate for protein assays. Total protein concentration was measured by BCA assay.
Western blotting
Western blotting was performed as described previously [17] . Briefly, purified SP-A was separated by SDS-PAGE and blotted onto PVDF transfer membranes. The membranes were blocked with 5% nonfat dry milk in TBS-T buffer (10 mM Tris, 0.1 M NaCl, 0.1% Tween 20, pH 7.4) at 4
• C overnight. Blots were incubated with the SP-A primary antibody (1:1000, donated by Dr Jennifer Condon) and antirabbit secondary antibody (1:5000). Proteins were detected using the ECL western blot detection system (GE Healthcare Bio-Sciences Corp., Piscataway, NJ) in a Storm imager (Molecular Dynamics, San Diego, CA).
Cytokine/chemokine assay
A panel of mouse proinflammatory cytokines (TNF, IL-6, and IFN-γ ), chemokines (MIP-1β), and an anti-inflammatory cytokine (IL-10) was assayed in total cell lysates with a Milliplex MAP kit (Millipore, St. Charles, MO) and a MAGPIX instrument (Millipore) as per the instructions of the manufacture. Equal amounts of protein (40 μg) were used for the assay. The assay was repeated three times with duplicates.
Flow cytometry
Decidual caps isolated from uteri and lumbar lymph nodes were prepared for animals from each of the four treatment groups (see above, tissue harvest for molecular and flow cytometry assays) as single-cell suspensions as described previously [37] . Briefly, tissues were minced in Hank balanced salt solution (Life technologies), mechanically dispersed through a 100-mm nylon filter, and centrifuged at 1500 rpm. The remaining pellet was dispersed in RPMI medium at 10 7 cells/ml in 48-well plates. The above specimens were incubated at 37
• C in 5% CO 2 /95% air for 1 h. Viability of ex vivo cultured cells was 95% as assessed using the trypan blue dye exclusion test. 
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Results
Surfactant protein A suppresses preterm delivery induced by infection with live bacteria
The right uterine horns of pregnant mice on day 14.5 of a 19-20 day gestation were inoculated with either sterile medium or live E. coli (1-3 × 10 3 bacteria per mouse). SP-A (100 or 200 μg/mouse, doses based upon prior dose-response experiments [17] ) or diluent alone was given by one of two routes (either IU or IV) and in one of two schedules (either simultaneously or 4 h after bacterial injection) ( Table 1) . Intrauterine injections were performed in the uterine lumen between fetal sacs. Delivery of one or more pups within 48 h was considered preterm. Neither LB medium nor SP-A alone produced preterm delivery or other observed anomalies in any of the dams tested (Table 1) . However, SP-A significantly suppressed bacterially induced preterm delivery, whether SP-A was given simultaneously IU, simultaneously IV, or IV 4 h after IU injections. In parallel, SP-A led to higher rates of retention of live fetuses in utero 48 h after surgery (Table 1 ). There were no statistically significant differences in efficacy between the two doses of SP-A. A control preparation depleted of SP-A by passage through a mannose column failed to prevent preterm delivery in otherwise identical and contemporaneous experiments.
The suppression of preterm delivery by surfactant protein A in infected mice is not attributable to inhibition of bacterial growth
To determine whether the delivery-suppressing effect of SP-A was due to inhibition of bacterial growth, the concentration of bacteria within decidual caps (i.e. the portion of the uterus directly underlying the placenta, expressed as CFU/g of tissue) and amniotic fluid (CFU/μl) was determined 8 h after treatment with either IU bacteria or sterile medium, and simultaneous IV infusion of either SP-A (200 μg/mouse) or diluent. There was no inhibition of bacterial growth by SP-A (Figure 1 ).
Surfactant protein A suppresses Escherichia coli-induced inflammation in gestational tissues in vivo
We and others have previously shown that preterm labor induced by activation of TLRs is associated with robust activation of inflammatory signaling in the decidual layer of the uterus [17, [38] [39] [40] . To explore whether SP-A's suppressive effect on bacterially induced labor is associated with suppression of the inflammatory response, cytokine assays were performed in tissues harvested 8 h after IU bacterial or control injections with and without simultaneous IV SP-A treatment.
Live E. coli treatment resulted in marked upregulation of a panel of proinflammatory mRNAs in decidua and placenta, including IL-1β, TNF, IL-6, iNOS, NLRP3, CCL2/MCP-1, and IL-22 (decidua only) but not CCL5 (Supplementary Figure S2 , not all markers assayed in placentas). IL-10 and IL-22 receptor were not affected by bacterial exposure. Though SP-A tended to counteract some of these bacterially induced changes, this did not achieve statistical significance (nonparametric testing with post hoc analysis). However, on the protein level (Figure 2 , measured in decidua using multiplex assay of homogenized tissues) SP-A exposure reversed all measured bacterially induced proinflammatory cytokine increases (i.e. TNF, IL-6, MIP1β, and IFNγ ), with no change in the anti-inflammatory cytokine IL-10. SP-A alone had no effect upon the above mRNAs or proteins, which were no different from medium-treated and three naïve animals (i.e. gestational age-matched controls that were neither anesthetized nor operated upon). These results suggest that SP-A Table 1 . SP-A suppresses preterm delivery induced by intrauterine (IU) inoculation with E. coli and leads to higher rates of retention of live fetuses in utero. Live E. coli were administered at 1-3 × 10 3 CFU IU per animal. Depleted SP-A was prepared by passage through a mannose column. "Preterm" = delivery of one or more pups within 48 h. P values calculated by contingency tables. reduces proinflammatory protein production by modulating posttranscriptional processes.
Live Escherichia coli induces macrophage polarization toward the M1 phenotype, an effect reversed by surfactant protein A
We and others have reported a large infiltration of macrophages into gestational tissues in both induced and spontaneous mouse labor [38, [41] [42] [43] . Gonzalez et al. showed that macrophage depletion by anti-F4/80 antibody prevented preterm delivery in LPS-treated mice [44] . Therefore, we studied the infiltration of macrophages and their polarization in decidua during live E. coli-induced preterm labor. Flow cytometry analysis 8 h after IU exposure to live E. coli showed that decidual macrophages (i.e. F4/80 + ) are polarized to the M1 phenotype (CD11c + ) with a decrease in both M2 (CD206 + ) and double-positive macrophages (CD11c + and CD206 + ) in comparison to controls (Figure 3 ). This polarization was completely reversed when SP-A was administered IV simultaneously with bacterial exposure, but not when IV diluent was given. Similar effects were noted in macrophages extracted from lumbar lymph nodes (data not shown).
Discussion
These experiments demonstrate the suppressive effects of a biological extract of SP-A on preterm labor in the mouse live infection model. It is remarkable that SP-A's interruption of labor occurs even when it is administered systemically rather than directly into the infected compartment. Furthermore, given that bacterial exposure almost always results in delivery in less than 24 h, the fact that IV SP-A infusion remains effective even when initiated after a 4-h delay is significant. These findings have implications for potential pharmacologic use of SP-A in women, in whom intra-amniotic infusion of medicines is not desirable, and in whom infectious processes are always diagnosed after they have already developed. Similar results were obtained in a previous report [17] , with the important distinction that in the current study infection with modest quantities of live E. coli (≤3000 organisms per animal) was used to stimulate labor, whereas prior experiments were conducted with large IU bolus exposures to TLR agonists (either LPS representing the content of approximately 10 9 bacteria [45] or the combination of PGN and poly(I: C)). The small quantities of live bacteria used in the present experiment more closely mimic ascending colonization of the gestational cavity (the mechanism thought to be responsible for most cases of IU infection [1] ). Escherichia coli were chosen for these experiments because they are one of the causes of intraamniotic infection. Prior work in our lab has demonstrated nearly identical molecular and preterm labor responses between heat-killed E. coli and LPS (both stimuli commonly used in animal models of infectioninduced preterm labor). In a systematic review of studies conducted in women with intra-amniotic infection using either molecular or culture techniques [46] , 83 different bacterial species were identified in 349 infected women. Escherichia coli were recovered from 6% of women. The only species more commonly isolated were various mycoplasmas/ureaplasmas (59%), Streptococcus agalactiae (11%), and Fusobacterium nucleatum (9%). The role of inflammation in the mechanisms of preterm parturition includes its effects on the expression of contraction-associated proteins, prostaglandin production, uterine contractions, cervical ripening, and other labor phenomena [47] [48] [49] [50] . It is useful to think of the inflammatory response in the context of infection-induced preterm labor as a protective reaction to a potentially life-threatening maternal infection within a closed body space (i.e. the equivalent of an abscess). By initiating labor, the host may preserve herself through emptying the infected cavity even if doing so comes at the cost of spontaneous delivery of nonsurviving offspring. This conflict between maternal and fetal interests parallels the dichotomy of the inflammatory response, which is both a key mechanism to eliminate infection and part of a cascade of events that can lead to organ dysfunction and death if left unchecked. How the optimal balance between the beneficial and harmful potential effects of inflammation is achieved is not well established. In prior work, we demonstrated that delivery is induced in the left uterine horn of the mouse after killed E. coli are injected into the right horn even though the injected horn was first surgically isolated from the contralateral horn at the cervix [51] . There was no change in the dose-response relationship between bacterial inoculum and the likelihood of preterm delivery comparing the intact bicornuate uterus with prior surgical isolation. This finding demonstrates that the mechanisms by which IU inflammation produces labor involve systemic signaling. Further strengthening this conclusion, we found that the noninjected horn delivered despite minimal increases in cytokine signals within the tissues.
In vitro and in vivo studies show that SP-A and SP-D enhance antibacterial responses by several mechanisms [16, 52] : (1) opsonization for uptake by immune cells; (2) agglutination/aggregation; (3) permeabilization of bacterial membranes; (4) blockade of pattern recognition receptors; (5) enhanced phagocytosis and phagocyte receptor expression; (6) enhanced superoxide burst; (7) enhanced chemotaxis; and (8) modulation of TLR functions. To study potential mechanisms underlying parturition in response to infection, we examined tissues harvested 8 h after IU bacterial inoculation with or without simultaneous IV SP-A treatment. There was no effect of SP-A on bacterial growth in either amniotic fluid or uteri. This makes it unlikely that the suppressive effect of SP-A on delivery following IV administration is due to direct enhancement of bacterial clearance. More likely it is related to a downstream consequence of bacterial infection or to altered bacterial virulence. Indeed, SP-A suppresses infection-induced increases in inflammatory cytokines in gestational tissues, a phenomenon that we find is due to effects on protein processing rather than transcription ( Supplementary Figure S2 and Figure 2) .
Finally, we document that macrophages (major mediators of inflammation during parturition [38, [41] [42] [43] [44] ) undergo polarization during IU infection toward the M1 phenotype (i.e. the classically activated/Th1/antibody-presenting type) and away from the M2 phenotype (i.e. the immune suppressive/tissue remodeling/Th2 type). This shift in polarization is expected during active parturition and especially during inflammation-induced parturition [53] , and is completely reversed by SP-A. In the previous work, we showed that sterile IU inflammation using TLR ligands leads to disruption of autophagic flux and promotion of inflammatory responses in gestational tissues, processes reversed by SP-A [54] . Crosstalk between autophagy and macrophage function has been described previously, including the observation that loss of autophagy promotes inflammation through enhancement of M1 polarization [55, 56] . The present results suggest that such crosstalk might be active in the infection-induced preterm labor model and that inhibition of this crosstalk might be part of the mechanism of labor suppression by SP-A.
Overall, the findings support the following conceptual model: IU infection leads to macrophage activation and polarization to the M1 phenotype and to the creation of a proinflammatory milieu, which in turn results in the constellation of events that constitutes labor. Exogenous SP-A can block this cascade by preventing development of the proinflammatory environment. Whether similar results would be generated with different SP-A dosing regimens remains to be determined.
SP-A may act either as a proinflammatory or anti-inflammatory agent depending on a variety of circumstances [16, 57] . In the absence of a pathogen, SP-A binds through its lectin domain to signal-inhibitory regulatory protein-α (SIRP-α). In the presence of a foreign organism or cellular debris, to which the lectin domain of SP-A binds, the free collagen-like region activates immune cells through the CD91-calreticulin complex. Engagement of the different receptors elicits different responses. When SP-A binds SIRP-α, inflammatory-mediator production is inhibited. By contrast, SP-A enhances inflammatory mediator production through the CD91-calreticulin complex [57] .
The findings of suppression by SP-A of labor and inflammation in the mouse, previously demonstrated in our lab in a series of experiments using TLR ligands as the labor stimulus [17] and now with live bacteria, stand to some degree at odds with previously published findings. SP-A has been suggested to serve as a signal for the onset of spontaneous parturition at term via an inflammatory mechanism [35] . A related report is that mice doubly deficient for SP-A and SP-D (a collectin similar to SP-A) have delayed spontaneous parturition by 12 h in second pregnancies, though not in first pregnancies, a phenomenon accompanied by diminished expression of inflammatory markers in myometrium and macrophages [58] . Finally, pregnant mice carrying fetuses with defective steroid receptor coactivators 1 and 2, which are important for SP-A production, have delayed parturition (though these animals have delayed luteolysis, which might represent an SP-A independent mechanism for failing to deliver) [59] .
Despite the above evidence supporting a role for SP-A in the onset of spontaneous parturition in mice, there are contrary findings, including: (1) in humans, the concentration of amniotic fluid [12] and decidual [60] SP-A decreases (rather than increasing) during labor, and no fetal macrophages are found in the myometrium after labor [12, 61, 62] ; (2) in chorioamnion, preterm labor without infection was associated with decreased (not increased) SP-A expression [63] ; (3) infiltration of fetal macrophages into maternal tissues, described by Condon in ICR mice, was not found in the C57BL/6 strain [12] ; (4) SP-A suppresses the production of inflammatory cytokines in human amnion explants [12] and of PGF2α and IL-1-induced inflammatory cytokines in human decidua and decidual macrophages [60, 64] .
It remains possible that SP-A signals for parturition at term under normal conditions (i.e. in the absence of infection) or in physiologic quantities, but that high-dose exogenous SP-A can act as a powerful suppressor of labor when an infectious or inflammatory threat is present. This duality in the actions of SP-A will need to be resolved before it can be considered as a pharmacologic agent to prevent preterm birth when infection is present.
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